Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of Novel Prognostic Prediction Models including the Prognostic Nutritional Index for Patients with Colorectal Cancer after Curative Resection.
Sasaki M, Miyoshi N, Fujino S, Ishikawa S, Saso K, Takahashi H, Haraguchi N, Hata T, Matsuda C, Mizushima T, Doki Y, Mori M. Sasaki M, et al. Among authors: ishikawa s. J Anus Rectum Colon. 2019 Jul 30;3(3):106-115. doi: 10.23922/jarc.2018-041. eCollection 2019. J Anus Rectum Colon. 2019. PMID: 31583325 Free PMC article.
Validation of the conventional Glasgow Prognostic Score and development of the improved Glasgow Prognostic Score in patients with stage 0-III colorectal cancer after curative resection.
Ishikawa S, Miyoshi N, Fujino S, Ogino T, Takahashi H, Uemura M, Yamamoto H, Mizushima T, Doki Y, Eguchi H. Ishikawa S, et al. Ann Gastroenterol Surg. 2021 Mar 2;5(3):345-353. doi: 10.1002/ags3.12426. eCollection 2021 May. Ann Gastroenterol Surg. 2021. PMID: 34095725 Free PMC article.
Reply to Letter to Editor Regarding Article "C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients".
Bekki T, Shimomura M, Yano T, Akabane S, Hattori M, Mochizuki T, Ono K, Matsubara K, Imaoka K, Ishikawa S, Watanabe A, Sato S, Ohdan H. Bekki T, et al. Among authors: ishikawa s. Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15300-1. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38679678 No abstract available.
Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients.
Aoki A, Iwamura C, Kiuchi M, Tsuji K, Sasaki A, Hishiya T, Hirasawa R, Kokubo K, Kuriyama S, Onodera A, Shimada T, Nagaoka T, Ishikawa S, Kojima A, Mito H, Hase R, Kasahara Y, Kuriyama N, Nakamura S, Urushibara T, Kaneda S, Sakao S, Nishida O, Takahashi K, Kimura MY, Motohashi S, Igari H, Ikehara Y, Nakajima H, Suzuki T, Hanaoka H, Nakada TA, Kikuchi T, Nakayama T, Yokote K, Hirahara K. Aoki A, et al. Among authors: ishikawa s. J Clin Immunol. 2024 Apr 22;44(4):104. doi: 10.1007/s10875-024-01708-7. J Clin Immunol. 2024. PMID: 38647550 Free PMC article.
3,341 results